EVLV vs AXON vs VNET vs CRNC

For growth investors, Evolv Technologies Holdings, Inc.

(EVLV) is the stronger pick with 40. 5% revenue growth year-over-year, versus -24. 0% for Cerence Inc. (CRNC). VNET Group, Inc. (VNET) offers the better valuation at 92. 4x trailing P/E (34. 7x forward), making it the more compelling value choice. Analysts rate Evolv Technologies Holdings, Inc. (EVLV) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, VNET Group, Inc.

(VNET) is the cheapest at 92. 4x versus Axon Enterprise, Inc. at 282. 7x. On forward P/E, Cerence Inc. is actually cheaper at 15. 3x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Axon Enterprise, Inc.

(AXON) delivered a total return of +216. 8%, compared to -88. 2% for Cerence Inc. (CRNC). Over 10 years, the gap is even starker: AXON returned +22. 0% versus CRNC's -58. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Axon Enterprise, Inc.

(AXON) is the lower-risk stock at 1. 19β versus Cerence Inc. 's 2. 82β — meaning CRNC is approximately 136% more volatile than AXON relative to the S&P 500. On balance sheet safety, Evolv Technologies Holdings, Inc. (EVLV) carries a lower debt/equity ratio of 35% versus 3% for VNET Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Evolv Technologies Holdings, Inc.

(EVLV) is pulling ahead at 40. 5% versus -24. 0% for Cerence Inc. (CRNC). On earnings-per-share growth, the picture is similar: VNET Group, Inc. grew EPS 103. 8% year-over-year, compared to -68. 5% for Axon Enterprise, Inc.. Over a 3-year CAGR, EVLV leads at 40. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Axon Enterprise, Inc.

(AXON) is the more profitable company, earning 4. 5% net margin versus -22. 7% for Evolv Technologies Holdings, Inc. — meaning it keeps 4. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VNET leads at 8. 1% versus -30. 7% for EVLV. At the gross margin level — before operating expenses — CRNC leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Cerence Inc.

(CRNC) trades at 15. 3x forward P/E versus 55. 0x for Axon Enterprise, Inc. — 39. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VNET: 162. 8% to $23. 55.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Axon Enterprise, Inc.

(AXON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 19)). Cerence Inc. (CRNC) carries a higher beta of 2. 82 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AXON: +22. 0%, CRNC: -58. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (EVLV (Industrials) and AXON (Industrials) and VNET (Technology) and CRNC (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EVLV is a small-cap high-growth stock; AXON is a mid-cap high-growth stock; VNET is a small-cap quality compounder stock; CRNC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.